4.8 Article

Structural basis for specific inhibition of the deubiquitinase UCHL1

期刊

NATURE COMMUNICATIONS
卷 13, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-33559-4

关键词

-

资金

  1. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [GE 3110/1-1, 424228829-SFB1430]
  2. AstraZeneca
  3. Merck KGaA
  4. Pfizer Inc.
  5. Max Planck Society as part of the Chemical Genomics Center III [CGCIII-352S]
  6. Deutsche Forschungsgemeinschaft and Technische Universitat Dortmund/TU Dortmund University

向作者/读者索取更多资源

This study reveals the structural basis for the specific inhibition of UCHL1 and introduces chemogenomic probes that can be used for investigating UCHL1 functions in living cells. Understanding the molecular roles of UCHL1 is important for studying cancer invasiveness and neurodegeneration. The newly developed probes provide valuable tools for cellular investigations of UCHL1.
The deubiquitinase UCHL1 has been linked to cancer invasiveness and neurodegeneration yet its molecular roles have remained poorly defined. Here the authors reveal the structural basis for how UCHL1 can be specifically inhibited and how chemogenomic probes can be used to dissect its functions in living cells. Ubiquitination regulates protein homeostasis and is tightly controlled by deubiquitinases (DUBs). Loss of the DUB UCHL1 leads to neurodegeneration, and its dysregulation promotes cancer metastasis and invasiveness. Small molecule probes for UCHL1 and DUBs in general could help investigate their function, yet specific inhibitors and structural information are rare. Here we report the potent and non-toxic chemogenomic pair of activity-based probes GK13S and GK16S for UCHL1. Biochemical characterization of GK13S demonstrates its stereoselective inhibition of cellular UCHL1. The crystal structure of UCHL1 in complex with GK13S shows the enzyme locked in a hybrid conformation of apo and Ubiquitin-bound states, which underlies its UCHL1-specificity within the UCH DUB family. Phenocopying a reported inactivating mutation of UCHL1 in mice, GK13S, but not GK16S, leads to reduced levels of monoubiquitin in a human glioblastoma cell line. Collectively, we introduce a set of structurally characterized, chemogenomic probes suitable for the cellular investigation of UCHL1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据